Works matching IS 02724391 AND DT 2003 AND VI 58 AND IP 4

Results: 26

Robert Berne: His place in the history of purine research.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 296, doi. 10.1002/ddr.10197

By:

Ray A. Olsson

Publication type:

Article

Expression and function of A2B adenosine receptors in the U87MG tumor cells.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 405, doi. 10.1002/ddr.10212

By:

Dewan Zeng;
Tenning Maa;
Uerica Wang;
Igor Feoktistov;
Italo Biaggioni;
Luiz Belardinelli

Publication type:

Article

Purines 2002.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 291, doi. 10.1002/ddr.10211

By:

John Headrick

Publication type:

Article

Dr. Robert M. Berne award for lifetime achievement in adenosine research.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 293, doi. 10.1002/ddr.10210

By:

Joel Linden

Publication type:

Article

Allosteric enhancers for adenosine receptors.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 493, doi. 10.1002/ddr.10198

By:

Ray A. Olsson

Publication type:

Article

Gene knockout approach to adenosine A2A receptors in Parkinson's disease.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 354, doi. 10.1002/ddr.10215

By:

Jiang-Fan Chen;
Michael A. Schwarzschild

Publication type:

Article

Cardioprotection with pre- and postischemic adenosine and A3 receptor activation: Differing mechanisms and effects on necrosis versus stunning.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 447, doi. 10.1002/ddr.10190

By:

Amanda Flood;
Laura Willems;
John P. Headrick

Publication type:

Article

Mechanisms of cardiac protection with Overexpression of A1 adenosine receptors.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 439, doi. 10.1002/ddr.10189

By:

Amy R. Lankford;
Rachael J. Cerniway;
Sara E. Regan;
Marguerite M. Crawford;
Anne M. Byford;
G. Paul Matherne

Publication type:

Article

Adenosine A3 receptors in the rat hippocampus: Lack of interaction with A1 receptors.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 428, doi. 10.1002/ddr.10188

By:

Luísa V. Lopes;
Nelson Rebola;
Ana Rita Costenla;
Linda Halldner;
Marlene A. Jacobson;
Catarina R. Oliveira;
Peter J. Richardson;
Bertil B. Fredholm;
Joaquim A. Ribeiro;
Rodrigo A. Cunha

Publication type:

Article

A3 receptors in cortical neurons: Pharmacological aspects and neuroprotection during hypoxia.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 420, doi. 10.1002/ddr.10187

By:

A. Lewerenz;
S. Hentschel;
Z. Vissiennon;
S. Michael;
K. Nieber

Publication type:

Article

Adenosine downregulates cytokine-induced expression of intercellular adhesion molecule-1 on rheumatoid synovial fibroblasts independently of adenosine receptor signaling.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 368, doi. 10.1002/ddr.10186

By:

Takashi Nakazawa;
Masahiro Koshiba;
Hidekazu Kosaka;
Goh Tsuji;
Yuji Nakamachi;
Ryuichi Saura;
Masahiro Kurosaka;
Yoshiya Tanaka;
Shunichi Kumagai

Publication type:

Article

Dissecting the regulatory mechanisms controlling inhibitory adenosine receptor signaling.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 302, doi. 10.1002/ddr.10185

By:

Timothy M. Palmer;
Gail Ferguson;
Kenneth R. Watterson

Publication type:

Article

Intracellular phosphorylation of chloro-adenosine analogs is a prerequisite for activation of caspase-3 and induction of apoptosis in human astrocytoma cells.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 396, doi. 10.1002/ddr.10184

By:

Stefania Ceruti;
Alessia Mazzola;
Elena Beltrami;
Davide Passera;
Elena Piantoni

Publication type:

Article

Effects of adenosine on prostate adenocarcinoma PC-3 and bladder carcinoma J82 cell lines.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 390, doi. 10.1002/ddr.10183

By:

Fabio Nucciarelli;
Ettore Mearini;
Alba Minelli

Publication type:

Article

Modulation of the A3 adenosine receptor by low agonist concentration induces antitumor and myelostimulatory effects.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 386, doi. 10.1002/ddr.10182

By:

Ofer Merimsky;
Sara Bar-Yehuda;
Lea Madi

Publication type:

Article

Adenosine receptors and human melanoma.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 377, doi. 10.1002/ddr.10181

By:

Stefania Merighi;
Pier Giovanni Baraldi;
Stefania Gessi;
Valeria Iannotta;
Karl-Norbert Klotz;
Edward Leung;
Prisco Mirandola;
Mojgan Aghazadeh Tabrizi;
Katia Varani;
Pier Andrea Borea

Publication type:

Article

Immunological characterization of A2B adenosine receptors in human mast cells.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 461, doi. 10.1002/ddr.10180

By:

Igor Feoktistov;
Anna Goldstein;
James R. Sheller;
Lawrence B. Schwartz

Publication type:

Article

Evidence of tanscriptional and tanslational components in anti-ischemic effects of adenosine.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 454, doi. 10.1002/ddr.10179

By:

John P. Headrick;
Jason Peart;
Kirsten Holmgren;
Kevin Ashton

Publication type:

Article

Impact of endogenous adenosine on airway hyperreactivity.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 472, doi. 10.1002/ddr.10178

By:

Michael R. Blackburn;
Hays W.J. Young

Publication type:

Article

Renal effects of BG9928, an A1 adenosine receptor antagonist, in rats and nonhuman primates.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 486, doi. 10.1002/ddr.10176

By:

Barry Ticho;
Eric Whalley;
Alan Gill;
Frank Lutterodt;
Xiaowei Jin;
John Auchampach;
Glenn Smits

Publication type:

Article

Inhibition of the nucleoside transporter inhibits disease progression in the rat adjuvant-induced arthritis model.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 479, doi. 10.1002/ddr.10175

By:

Hidekazu Kosaka;
Masahiro Koshiba;
Takashi Nakazawa;
Goh Tsuji;
Jun Saegusa;
Sugayo Kanagawa;
Ryuichi Saura;
Masahiro Kurosaka;
Shin Yoshino;
Shunichi Kumagai

Publication type:

Article

In vivo studies of the release of adenine 5'-nucleotides, adenosine, and its metabolites from the rat brain.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 412, doi. 10.1002/ddr.10173

By:

John W. Phillis;
Michael H. O'Regan

Publication type:

Article

Consequences of eliminating adenosine A1 receptors in mice.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 350

By:

Bertil B. Fredholm;
Linda Halldner;
Catarina Johansson;
Gunnar Schulte;
Cecilia Lövdahl;
Peter Thorén;
Thomas V. Dunwiddie;
Susan A. Masino;
Wolfgang Poelchen;
Lihong Diao;
Peter Illes;
Nancy R. Zahniser;
Guro Valen;
Shinichi Tokuno;
Hilchen Sommerschild;
Lydia Giménez-Llort;
Alberto Fernández-Teruel;
Rosa M. Escorihuela;
Zsuzsanna Wiesenfeld-Hallin;
Xiao-Jun Xu

Publication type:

Article

Hetero-oligomerization between adenosine A1 and P2Y1 receptors in living cells: Formation of ATP-sensitive adenosine receptors.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 340, doi. 10.1002/ddr.10169

By:

Hiroyasu Nakata;
Kazuaki Yoshioka;
Osamu Saitoh

Publication type:

Article

Engineering of A3 adenosine and P2Y nucleotide receptors and their ligands.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 330, doi. 10.1002/ddr.10168

By:

Kenneth A. Jacobson;
Hak Sung Kim;
Gnana Ravi;
Soo-Kyung Kim;
Kyeong Lee;
Aishe Chen;
Wangzhong Chen;
Seong Gon Kim;
Dov Barak;
Bruce T. Liang;
Zhan-Guo Gao

Publication type:

Article

Recent developments in the field of A3 adenosine receptor antagonists.

Published in:

Drug Development Research, 2003, v. 58, n. 4, p. 315, doi. 10.1002/ddr.10167

By:

Pier Giovanni Baraldi;
Mojgan Aghazadeh Tabrizi;
Francesca Fruttarolo;
Andrea Bovero;
Barbara Avitabile;
Delia Preti;
Romeo Romagnoli;
Stefania Merighi;
Stefania Gessi;
Katia Varani;
Pier Andrea Borea

Publication type:

Article

Works matching IS 02724391 AND DT 2003 AND VI 58 AND IP 4

Robert Berne: His place in the history of purine research.

Expression and function of A<sub>2B</sub> adenosine receptors in the U87MG tumor cells.

Purines 2002.

Dr. Robert M. Berne award for lifetime achievement in adenosine research.

Allosteric enhancers for adenosine receptors.

Gene knockout approach to adenosine A<sub>2A</sub> receptors in Parkinson's disease.

Cardioprotection with pre- and postischemic adenosine and A<sub>3</sub> receptor activation: Differing mechanisms and effects on necrosis versus stunning.

Mechanisms of cardiac protection with Overexpression of A<sub>1</sub> adenosine receptors.

Adenosine A<sub>3</sub> receptors in the rat hippocampus: Lack of interaction with A<sub>1</sub> receptors.

A<sub>3</sub> receptors in cortical neurons: Pharmacological aspects and neuroprotection during hypoxia.

Adenosine downregulates cytokine-induced expression of intercellular adhesion molecule-1 on rheumatoid synovial fibroblasts independently of adenosine receptor signaling.

Dissecting the regulatory mechanisms controlling inhibitory adenosine receptor signaling.

Intracellular phosphorylation of chloro-adenosine analogs is a prerequisite for activation of caspase-3 and induction of apoptosis in human astrocytoma cells.

Effects of adenosine on prostate adenocarcinoma PC-3 and bladder carcinoma J82 cell lines.

Modulation of the A<sub>3</sub> adenosine receptor by low agonist concentration induces antitumor and myelostimulatory effects.

Adenosine receptors and human melanoma.

Immunological characterization of A<sub>2B</sub> adenosine receptors in human mast cells.

Evidence of tanscriptional and tanslational components in anti-ischemic effects of adenosine.

Impact of endogenous adenosine on airway hyperreactivity.

Renal effects of BG9928, an A<sub>1</sub> adenosine receptor antagonist, in rats and nonhuman primates.

Inhibition of the nucleoside transporter inhibits disease progression in the rat adjuvant-induced arthritis model.

In vivo studies of the release of adenine 5'-nucleotides, adenosine, and its metabolites from the rat brain.

Consequences of eliminating adenosine A<sub>1</sub> receptors in mice.

Hetero-oligomerization between adenosine A<sub>1</sub> and P2Y<sub>1</sub> receptors in living cells: Formation of ATP-sensitive adenosine receptors.

Engineering of A<sub>3</sub> adenosine and P2Y nucleotide receptors and their ligands.

Recent developments in the field of A<sub>3</sub> adenosine receptor antagonists.